Memantine prevents quinolinic acid-induced hippocampal damage
- 1 September 1992
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 219 (3-4) , 451-454
- https://doi.org/10.1016/0014-2999(92)90487-o
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Memantine displaces [3H]MK-801 at therapeutic concentrations in postmortem human frontal cortexPublished by Elsevier ,2002
- Memantine is highly potent in protecting cortical cultures against excitotoxic cell death evoked by glutamate and N-methyl-D-aspartateEuropean Journal of Pharmacology, 1991
- Effects of MK-801, ketamine and alaptide on quinolinate models in the maturing hippocampusNeuroscience, 1991
- Subcutaneously applied magnesium protects reliably against quinolinate-induced (NMDA)-mediated neurodegeneration and convulsions in rats: Are there therapeutical implications?Neuroscience Letters, 1990
- Neuroprotective effect of memantine demonstrated in vivo and in vitroEuropean Journal of Pharmacology, 1990
- Granule cells in the ventral, but not dorsal, dentate gyrus are essential for kainic acid-induced wet dog shakesBrain Research, 1990
- Quinolinate neurotoxicity and glutamatergic structuresNeuroscience, 1990
- Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channelsEuropean Journal of Pharmacology, 1989
- Hippocampal mediation of shaking behavior induced by electrical stimulation of the perforant path in the ratBrain Research, 1984